Download FREE Report Sample
Download Free sampleViral Vectors Non-Viral Vectors and Gene Therapy Market contains market size and forecasts of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in Global, including the following market information:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AAV Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Type, 2021 (%)
AAV
Adenoviral
Lentiviral
Retroviral
Plasmid DNA
Other Vectors
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Application, 2021 (%)
Cancers
Inherited Disorders
Viral Infections
Others
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
bluebird bio
Novasep
Spark Therapeutics
Vigene Biosciences
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
